Stock Analysis

Earnings Miss: Here's What Quaker Chemical Corporation (NYSE:KWR) Analysts Are Forecasting For This Year

NYSE:KWR
Source: Shutterstock

Quaker Chemical Corporation (NYSE:KWR) just released its latest quarterly report and things are not looking great. Results look to have been somewhat negative - revenue fell 6.1% short of analyst estimates at US$464m, and statutory earnings of US$1.94 per share missed forecasts by 6.7%. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year.

View our latest analysis for Quaker Chemical

earnings-and-revenue-growth
NYSE:KWR Earnings and Revenue Growth August 8th 2024

Following last week's earnings report, Quaker Chemical's six analysts are forecasting 2024 revenues to be US$1.89b, approximately in line with the last 12 months. Statutory earnings per share are predicted to soar 21% to US$8.36. In the lead-up to this report, the analysts had been modelling revenues of US$1.95b and earnings per share (EPS) of US$8.36 in 2024. The consensus seems maybe a little more pessimistic, trimming their revenue forecasts after the latest results even though there was no change to its EPS estimates.

The average price target was steady at US$219even though revenue estimates declined; likely suggesting the analysts place a higher value on earnings. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. The most optimistic Quaker Chemical analyst has a price target of US$240 per share, while the most pessimistic values it at US$179. With such a narrow range of valuations, the analysts apparently share similar views on what they think the business is worth.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. These estimates imply that revenue is expected to slow, with a forecast annualised decline of 0.2% by the end of 2024. This indicates a significant reduction from annual growth of 13% over the last five years. Compare this with our data, which suggests that other companies in the same industry are, in aggregate, expected to see their revenue grow 4.8% per year. It's pretty clear that Quaker Chemical's revenues are expected to perform substantially worse than the wider industry.

The Bottom Line

The most obvious conclusion is that there's been no major change in the business' prospects in recent times, with the analysts holding their earnings forecasts steady, in line with previous estimates. On the negative side, they also downgraded their revenue estimates, and forecasts imply they will perform worse than the wider industry. Still, earnings are more important to the intrinsic value of the business. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Quaker Chemical going out to 2026, and you can see them free on our platform here..

You can also view our analysis of Quaker Chemical's balance sheet, and whether we think Quaker Chemical is carrying too much debt, for free on our platform here.

Valuation is complex, but we're here to simplify it.

Discover if Quaker Chemical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.